Buy Magic Mushrooms: A Step-By-Step Guide

The use of psychedelic mushrooms, often referred to as magic mushrooms, has been gaining traction in recent years, with a growing movement to decriminalize and legalize their use. While the active ingredients in these mushrooms, psilocybin and psilocin, are classified as controlled substances in many places, there is increasing interest in their therapeutic potential for treating mental health conditions such as depression, anxiety, and PTSD. As a result, the demand for psychedelic mushrooms is increasing, and new cultivation methods are making them stronger and more potent. However, it is important to note that the effects of magic mushrooms can vary widely and may include negative side effects such as nausea, anxiety, paranoia, and, in rare cases, even death. With the potential risks and legal considerations involved, it is essential to approach the topic of purchasing and consuming psychedelic mushrooms with caution and to stay informed about the latest research and regulations.

Legality: In Canada, the US, and internationally, magic mushrooms are controlled substances

Magic mushrooms, or psilocybin mushrooms, are considered controlled substances in Canada, the US, and many other countries. However, the legal status of these mushrooms and their active compounds, psilocybin and psilocin, is evolving, with an increasing movement towards decriminalization and therapeutic use.

In Canada, the Controlled Drugs and Substances Act (CDSA) classifies psilocybin and psilocin as controlled substances. Under the CDSA, activities such as the sale, possession, and production of magic mushrooms are generally illegal without authorization from Health Canada. While there is no formal decriminalization at the federal level, some Canadian provinces and municipalities have implemented local decriminalization measures and medical exemptions. For example, the province of Alberta has allowed the use of psilocybin for medicinal purposes in drug-assisted psychotherapy, and British Columbia launched a pilot decriminalization program in 2023 for certain medications, excluding psilocybin. Additionally, Health Canada has granted exemptions for therapeutic use to patients with end-of-life distress and other severe illnesses since 2020.

In the United States, the legal status of psilocybin mushrooms varies at the state level. While federal regulations, such as the Psychotropic Substances Act of 1978, prohibit the possession and use of psilocybin, several states and cities have taken steps towards decriminalization or have made enforcement of laws against possession and use a low priority. For instance, Oregon and the District of Columbia passed initiatives to allow the possession and non-for-profit distribution of psilocybin mushrooms for mental health treatment. Colorado became the second state to decriminalize psilocybin mushrooms in 2022, and cities like Denver and Oakland have also passed decriminalization laws. However, some states, like California, Georgia, and Idaho, have specifically prohibited the sale and possession of psilocybin mushroom spores.

Internationally, psilocybin and psilocin are listed as Schedule I drugs under the United Nations 1971 Convention on Psychotropic Substances, which requires members to prohibit or strictly control the use of the drug. Many countries have some level of regulation or prohibition, such as the UK, Australia, and Japan. However, there is a growing movement worldwide to decriminalize and explore the therapeutic potential of psychedelic mushrooms, particularly in the treatment of mental health conditions.

Safety: Magic mushrooms can cause hallucinations, anxiety, paranoia, and nausea

While the use of psychedelic mushrooms is becoming more accepted, it is important to remember that they can be dangerous and have adverse effects on users. Magic mushrooms can cause hallucinations, anxiety, paranoia, and nausea. The effects of magic mushrooms vary from person to person and can be unpredictable. The strength of the mushrooms, the dose, and the type of mushroom consumed all play a role in determining the effects.

Hallucinations are one of the most well-known effects of magic mushrooms. Psilocybin and psilocin, the active ingredients in magic mushrooms, are hallucinogens that produce effects similar to LSD. These substances alter a person's sense of reality and affect their judgment, making activities like driving while under the influence dangerous and likely to cause accidents.

In addition to hallucinations, magic mushrooms can also cause anxiety and paranoia. Higher doses or stronger mushrooms can lead to intense paranoia, panic attacks, and fears of death. Some users may experience terrifying thoughts of losing control, and there is no way to end a "bad trip" until it has run its course, which could take hours.

Nausea is another common side effect of magic mushroom consumption. Early effects of magic mushrooms often include nausea, excessive yawning, and stomach cramps. Some users may also experience diarrhea. In rare cases, taking a large dose of magic mushrooms can lead to a long-term mental health condition known as psychosis.

It is also important to note that while it is difficult to become physically or psychologically dependent on magic mushrooms, it is possible to develop a tolerance to their effects with regular use. This means that over time, larger amounts of the drug will be needed to achieve the desired effects. Additionally, some mushrooms may be poisonous, and consuming them can have serious health consequences or even lead to death. Therefore, it is essential to exercise caution and be aware of the potential risks associated with magic mushroom consumption.

Effects: The length and intensity of a trip depend on the dose, type of mushroom, and individual factors

The effects of psychedelic mushrooms are subjective and vary among individuals. The length and intensity of a trip depend on the dose, type of mushroom, and personal factors.

Doses of psilocybin mushrooms typically range from 1.0 to 3.5–5.0 g of dried mushrooms and 10 to 50 g of fresh mushrooms. A "heroic dose" is considered to be 5.0 g of dried mushrooms. The effects of a "heroic dose" can be intense and long-lasting, with noticeable changes in sensory experiences occurring within 30 minutes to an hour of ingestion. The first 3–4 hours after ingestion are typically referred to as the 'peak', with more intense visuals and distortions of reality. The effects can seem longer due to psilocybin's ability to alter time perception.

The type of mushroom also plays a role in the length and intensity of the trip. Different species of psilocybin-containing mushrooms, such as Psilocybe and Gymnopilus, can vary in potency and psilocybin content, influencing the overall experience. Additionally, the preparation method and personal metabolism influence the duration and strength of the effects.

Personal factors, such as an individual's mood, expectations, past experiences, and environment, also contribute to the length and intensity of the trip. Being in a positive state of mind, having trusted company, and being in a safe and familiar environment can enhance the experience. Conversely, feelings of stress, anxiety, or being in a negative environment can increase the likelihood of a challenging trip. It is important to note that mixing magic mushrooms with other drugs or medications can lead to unpredictable and dangerous consequences.

Medical uses: Research suggests psilocybin may be effective in treating depression, anxiety, and PTSD

While the use of psychedelic mushrooms is currently illegal in the United States, there is a growing movement to decriminalize these substances, particularly for therapeutic use. In fact, some cities have already passed laws that make the enforcement of laws against the possession and use of psychedelic mushrooms a low priority. This shift in attitude is largely driven by the growing body of scientific research that suggests psilocybin, the psychedelic compound found in magic mushrooms, may be effective in treating mental health conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD).

Psilocybin has been shown to produce changes in brain activity that can help alleviate symptoms of depression. Clinical trials have found that participants with depression who were given psilocybin reported significant improvements in their mood, as well as reduced anxiety and feelings of hopelessness. These positive effects were long-lasting, with some participants in a study by Johns Hopkins Medicine researchers experiencing relief from depressive symptoms for up to a year after psilocybin-assisted therapy. Another study published in the New England Journal of Medicine also found that a single dose of psilocybin, along with psychological support, was effective in treating adults with treatment-resistant depression.

In addition to depression, psilocybin has also been found to be effective in treating anxiety, particularly in patients with cancer. A small double-blind study by Johns Hopkins researchers found that a large majority of people with cancer-related anxiety or depression experienced relief for up to six months after a single large dose of psilocybin. Furthermore, psilocybin has been found to be effective in reducing anxiety and facilitating smoking cessation as part of cognitive-behavioral therapy.

Psilocybin also shows potential in treating PTSD. The Johns Hopkins Center for Psychedelic and Consciousness Research is currently investigating the effectiveness of psilocybin as a new therapy for PTSD, among other mental illnesses. As research into the therapeutic potential of psilocybin expands and cultural acceptance grows, it is likely that demand for psychedelic mushrooms will increase. However, it is important to note that the use of psilocybin should be approached with caution and only under the guidance of trained medical professionals, as it can have adverse effects such as headaches, nausea, dizziness, and fatigue.

Purchase risks: It can be hard to distinguish between mushroom species, and some are poisonous

There are many risks associated with purchasing psychedelic mushrooms. Firstly, it is important to distinguish between different mushroom species, as some are poisonous and can be lethally toxic. While some mushrooms are distinctive in appearance, many are not, and different species can look very similar. Therefore, it is crucial to be detail-oriented when identifying mushrooms. The size, colour, and shape of the cap and stem are important diagnostic features, as is the presence of pores, gills, or teeth on the underside of the cap. The colour of the mushroom's flesh and spores is also significant, and spore prints can be made to determine spore colour.

Amanita species, for example, often have both an annulus (a skirt of tissue around the circumference of the stipe) and a volva (a sack of tissue at the base of the stipe), and many of these species are poisonous. Mushrooms in the Pleurotus genus, or "oyster mushrooms," are characterized by their broad, fan-shaped, or oyster-shaped caps, and they typically grow on wood or debris. The Melanoleuca genus includes medium to large-sized fungi commonly found in grasslands, meadows, and wooded areas, with white spore prints and smooth caps that are often flat with a central umbo.

It is also important to note that the same species of mushroom can look different at various stages of development, and young specimens can be particularly misleading. Wild mushrooms should be avoided, as they can be challenging to identify accurately. Joining a local mycology association or a club like the Michigan Mushroom Hunters Club can provide hands-on experience with experts in mushroom identification. Additionally, websites like Mushroom Expert and the University of Wisconsin-La Crosse's Fungi site offer colour photos of fungi for reference. However, it is advised not to use these solely as a basis for consuming mushrooms.

In terms of safety, it is worth noting that the decriminalization and legalization of psychedelic mushrooms are gaining momentum in certain cities and states, which has led to increased interest and demand. As a result, there is growing research into the therapeutic potential of these substances, particularly in treating mental health conditions such as depression, anxiety, PTSD, and addiction. While this may lead to greater acceptance of psychedelic therapies, it is important to approach the purchase and consumption of psychedelic mushrooms with caution due to the potential risks involved.

Frequently asked questions